WEST PHARMACEUTICAL SERVICES (WST) Stock Fundamental Analysis

NYSE:WST • US9553061055

249.1 USD
-2.15 (-0.86%)
Last: Mar 3, 2026, 11:23 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

7

WST gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 57 industry peers in the Life Sciences Tools & Services industry. WST scores excellent points on both the profitability and health parts. This is a solid base for a good stock. WST is not valued too expensively and it also shows a decent growth rate. With these ratings, WST could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • WST had positive earnings in the past year.
  • WST had a positive operating cash flow in the past year.
  • WST had positive earnings in each of the past 5 years.
  • In the past 5 years WST always reported a positive cash flow from operatings.
WST Yearly Net Income VS EBIT VS OCF VS FCFWST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

1.2 Ratios

  • WST has a better Return On Assets (11.56%) than 92.98% of its industry peers.
  • The Return On Equity of WST (15.54%) is better than 89.47% of its industry peers.
  • WST has a better Return On Invested Capital (13.83%) than 94.74% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for WST is above the industry average of 11.60%.
Industry RankSector Rank
ROA 11.56%
ROE 15.54%
ROIC 13.83%
ROA(3y)13.53%
ROA(5y)15.35%
ROE(3y)18.17%
ROE(5y)20.93%
ROIC(3y)15.69%
ROIC(5y)17.84%
WST Yearly ROA, ROE, ROICWST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • Looking at the Profit Margin, with a value of 16.06%, WST belongs to the top of the industry, outperforming 87.72% of the companies in the same industry.
  • In the last couple of years the Profit Margin of WST has remained more or less at the same level.
  • WST's Operating Margin of 20.16% is amongst the best of the industry. WST outperforms 85.96% of its industry peers.
  • In the last couple of years the Operating Margin of WST has remained more or less at the same level.
  • WST has a Gross Margin (35.91%) which is comparable to the rest of the industry.
  • WST's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 20.16%
PM (TTM) 16.06%
GM 35.91%
OM growth 3Y-8.65%
OM growth 5Y0.48%
PM growth 3Y-7.51%
PM growth 5Y-0.08%
GM growth 3Y-3.01%
GM growth 5Y0.08%
WST Yearly Profit, Operating, Gross MarginsWST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), WST is creating some value.
  • WST has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for WST has been reduced compared to 5 years ago.
  • The debt/assets ratio for WST has been reduced compared to a year ago.
WST Yearly Shares OutstandingWST Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
WST Yearly Total Debt VS Total AssetsWST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • An Altman-Z score of 12.92 indicates that WST is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of WST (12.92) is better than 98.25% of its industry peers.
  • WST has a debt to FCF ratio of 0.43. This is a very positive value and a sign of high solvency as it would only need 0.43 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 0.43, WST belongs to the best of the industry, outperforming 92.98% of the companies in the same industry.
  • WST has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
  • WST has a Debt to Equity ratio of 0.06. This is in the better half of the industry: WST outperforms 64.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.43
Altman-Z 12.92
ROIC/WACC1.3
WACC10.66%
WST Yearly LT Debt VS Equity VS FCFWST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 3.02 indicates that WST has no problem at all paying its short term obligations.
  • WST has a Current ratio of 3.02. This is comparable to the rest of the industry: WST outperforms 54.39% of its industry peers.
  • WST has a Quick Ratio of 2.34. This indicates that WST is financially healthy and has no problem in meeting its short term obligations.
  • With a Quick ratio value of 2.34, WST perfoms like the industry average, outperforming 52.63% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.02
Quick Ratio 2.34
WST Yearly Current Assets VS Current LiabilitesWST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 8.00% over the past year.
  • The Earnings Per Share has been growing by 8.94% on average over the past years. This is quite good.
  • WST shows a small growth in Revenue. In the last year, the Revenue has grown by 6.25%.
  • WST shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.44% yearly.
EPS 1Y (TTM)8%
EPS 3Y-5.25%
EPS 5Y8.94%
EPS Q2Q%12.09%
Revenue 1Y (TTM)6.25%
Revenue growth 3Y2.12%
Revenue growth 5Y7.44%
Sales Q2Q%7.51%

3.2 Future

  • Based on estimates for the next years, WST will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.76% on average per year.
  • WST is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.99% yearly.
EPS Next Y7.67%
EPS Next 2Y10.28%
EPS Next 3Y10.83%
EPS Next 5Y10.76%
Revenue Next Year6.11%
Revenue Next 2Y6.14%
Revenue Next 3Y6.41%
Revenue Next 5Y5.99%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
WST Yearly Revenue VS EstimatesWST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B
WST Yearly EPS VS EstimatesWST Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • WST is valuated quite expensively with a Price/Earnings ratio of 34.17.
  • WST's Price/Earnings is on the same level as the industry average.
  • When comparing the Price/Earnings ratio of WST to the average of the S&P500 Index (27.13), we can say WST is valued slightly more expensively.
  • WST is valuated quite expensively with a Price/Forward Earnings ratio of 31.74.
  • 61.40% of the companies in the same industry are more expensive than WST, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.11, WST is valued at the same level.
Industry RankSector Rank
PE 34.17
Fwd PE 31.74
WST Price Earnings VS Forward Price EarningsWST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • 64.91% of the companies in the same industry are more expensive than WST, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, WST is valued a bit cheaper than the industry average as 63.16% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 38.22
EV/EBITDA 22.1
WST Per share dataWST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates WST does not grow enough to justify the current Price/Earnings ratio.
  • The excellent profitability rating of WST may justify a higher PE ratio.
PEG (NY)4.45
PEG (5Y)3.82
EPS Next 2Y10.28%
EPS Next 3Y10.83%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.32%, WST is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.10, WST pays a better dividend. On top of this WST pays more dividend than 84.21% of the companies listed in the same industry.
  • With a Dividend Yield of 0.32, WST pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.32%

5.2 History

  • The dividend of WST has a limited annual growth rate of 5.48%.
  • WST has paid a dividend for at least 10 years, which is a reliable track record.
  • WST has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)5.48%
Div Incr Years32
Div Non Decr Years34
WST Yearly Dividends per shareWST Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8

5.3 Sustainability

  • WST pays out 12.40% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of WST is growing, but earnings are growing more, so the dividend growth is sustainable.
DP12.4%
EPS Next 2Y10.28%
EPS Next 3Y10.83%
WST Yearly Income VS Free CF VS DividendWST Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
WST Dividend Payout.WST Dividend Payout, showing the Payout Ratio.WST Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

WEST PHARMACEUTICAL SERVICES

NYSE:WST (3/3/2026, 11:23:19 AM)

249.1

-2.15 (-0.86%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-12
Earnings (Next)04-22
Inst Owners97.92%
Inst Owner Change-2.12%
Ins Owners0.33%
Ins Owner Change0.38%
Market Cap17.92B
Revenue(TTM)3.07B
Net Income(TTM)493.70M
Analysts80.87
Price Target328.99 (32.07%)
Short Float %3.13%
Short Ratio2.33
Dividend
Industry RankSector Rank
Dividend Yield 0.32%
Yearly Dividend0.85
Dividend Growth(5Y)5.48%
DP12.4%
Div Incr Years32
Div Non Decr Years34
Ex-Date04-29
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.82%
Min EPS beat(2)10.24%
Max EPS beat(2)15.4%
EPS beat(4)4
Avg EPS beat(4)15.68%
Min EPS beat(4)10.24%
Max EPS beat(4)20.68%
EPS beat(8)7
Avg EPS beat(8)12.16%
EPS beat(12)11
Avg EPS beat(12)11.7%
EPS beat(16)14
Avg EPS beat(16)11.27%
Revenue beat(2)2
Avg Revenue beat(2)0.72%
Min Revenue beat(2)0.33%
Max Revenue beat(2)1.1%
Revenue beat(4)4
Avg Revenue beat(4)1.63%
Min Revenue beat(4)0.33%
Max Revenue beat(4)4.33%
Revenue beat(8)7
Avg Revenue beat(8)1.11%
Revenue beat(12)8
Avg Revenue beat(12)0.49%
Revenue beat(16)10
Avg Revenue beat(16)0.34%
PT rev (1m)-7.08%
PT rev (3m)-6.97%
EPS NQ rev (1m)1.65%
EPS NQ rev (3m)1.85%
EPS NY rev (1m)0%
EPS NY rev (3m)1.03%
Revenue NQ rev (1m)2.4%
Revenue NQ rev (3m)2.48%
Revenue NY rev (1m)-0.15%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 34.17
Fwd PE 31.74
P/S 5.83
P/FCF 38.22
P/OCF 23.74
P/B 5.64
P/tB 5.86
EV/EBITDA 22.1
EPS(TTM)7.29
EY2.93%
EPS(NY)7.85
Fwd EY3.15%
FCF(TTM)6.52
FCFY2.62%
OCF(TTM)10.49
OCFY4.21%
SpS42.73
BVpS44.15
TBVpS42.51
PEG (NY)4.45
PEG (5Y)3.82
Graham Number85.1
Profitability
Industry RankSector Rank
ROA 11.56%
ROE 15.54%
ROCE 17.14%
ROIC 13.83%
ROICexc 17.71%
ROICexgc 18.48%
OM 20.16%
PM (TTM) 16.06%
GM 35.91%
FCFM 15.25%
ROA(3y)13.53%
ROA(5y)15.35%
ROE(3y)18.17%
ROE(5y)20.93%
ROIC(3y)15.69%
ROIC(5y)17.84%
ROICexc(3y)20.15%
ROICexc(5y)23.86%
ROICexgc(3y)21.15%
ROICexgc(5y)25.26%
ROCE(3y)19.45%
ROCE(5y)22.11%
ROICexgc growth 3Y-14.58%
ROICexgc growth 5Y-3.63%
ROICexc growth 3Y-14.12%
ROICexc growth 5Y-2.75%
OM growth 3Y-8.65%
OM growth 5Y0.48%
PM growth 3Y-7.51%
PM growth 5Y-0.08%
GM growth 3Y-3.01%
GM growth 5Y0.08%
F-Score7
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.43
Debt/EBITDA 0.26
Cap/Depr 166.8%
Cap/Sales 9.3%
Interest Coverage 2065.67
Cash Conversion 95.41%
Profit Quality 94.98%
Current Ratio 3.02
Quick Ratio 2.34
Altman-Z 12.92
F-Score7
WACC10.66%
ROIC/WACC1.3
Cap/Depr(3y)224.35%
Cap/Depr(5y)223.25%
Cap/Sales(3y)11.53%
Cap/Sales(5y)10.68%
Profit Quality(3y)73.64%
Profit Quality(5y)69.18%
High Growth Momentum
Growth
EPS 1Y (TTM)8%
EPS 3Y-5.25%
EPS 5Y8.94%
EPS Q2Q%12.09%
EPS Next Y7.67%
EPS Next 2Y10.28%
EPS Next 3Y10.83%
EPS Next 5Y10.76%
Revenue 1Y (TTM)6.25%
Revenue growth 3Y2.12%
Revenue growth 5Y7.44%
Sales Q2Q%7.51%
Revenue Next Year6.11%
Revenue Next 2Y6.14%
Revenue Next 3Y6.41%
Revenue Next 5Y5.99%
EBIT growth 1Y5.95%
EBIT growth 3Y-6.72%
EBIT growth 5Y7.96%
EBIT Next Year43.23%
EBIT Next 3Y19.91%
EBIT Next 5Y14.42%
FCF growth 1Y69.65%
FCF growth 3Y2.19%
FCF growth 5Y9.48%
OCF growth 1Y15.52%
OCF growth 3Y1.4%
OCF growth 5Y9.82%

WEST PHARMACEUTICAL SERVICES / WST FAQ

What is the fundamental rating for WST stock?

ChartMill assigns a fundamental rating of 7 / 10 to WST.


What is the valuation status for WST stock?

ChartMill assigns a valuation rating of 4 / 10 to WEST PHARMACEUTICAL SERVICES (WST). This can be considered as Fairly Valued.


Can you provide the profitability details for WEST PHARMACEUTICAL SERVICES?

WEST PHARMACEUTICAL SERVICES (WST) has a profitability rating of 8 / 10.


Can you provide the financial health for WST stock?

The financial health rating of WEST PHARMACEUTICAL SERVICES (WST) is 8 / 10.


How sustainable is the dividend of WEST PHARMACEUTICAL SERVICES (WST) stock?

The dividend rating of WEST PHARMACEUTICAL SERVICES (WST) is 6 / 10 and the dividend payout ratio is 12.4%.